SURPASS Webinar and Proposers' Day Information
- Client
- Department of Health and Human Services
- RFP Number
- —
- Posted
- 10/2/2026
- Category
- US Federal
- Budget
- —
- NAICS
- 541714
- Set-aside
- —
- Contact
- The SURPASS Team
- [email protected]
Description
AI GeneratedThe Advanced Research Projects Agency for Health seeks to inform the scientific community about the Simulation-augmented, Real-time Platform Adaptive Seamless Trials program. Interested parties can participate in an online informational webinar on October 15, 2026, and a hybrid Proposers' Day on November 6 and 9, 2026, to learn about program goals, ask questions, and identify potential team members. Applicants must register online by October 12, 2026, for the webinar and by October 28, 2026, for the Proposers' Day. Attendees may optionally submit teaming profiles, present one-slide lightning talks, or participate in poster sessions, though attendance and these deliverables are not required to submit future proposals or receive funding. Questions submitted at least three business days prior to the events may be addressed during the sessions.
Official SAM.gov notice
- Solicitation number
- ARPA-H-SN-26-164
- Agency
- Department of Health and Human Services
- Buying office
- National Institutes of Health › Advanced Research Projects Agency for Health (Arpa-H)
- Notice type
- Special Notice
- Responses due
- Oct 12, 2026, 11:59 PM ET
- Posted on SAM.gov
- Sep 30, 2026
- NAICS
- 541714 · Research and Development in Biotechnology (except Nanobiotechnology)
- Product/service code
- AN13
- Contracting contact
- The SURPASS Team
[email protected]
Read the official notice description
The Advanced Research Projects Agency for Health (ARPA-H) posts this Special Notice in support of its Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) Program. Interested parties are invited to review the attached Notice related to an informational webinar on 15 OCT 2026 and a 2-day Proposers’ Day on 6 and 9 NOV 2026 in support of SURPASS. For more information related to the SURPASS opportunity, see solicitation ARPA-H-SOL-26-164. All questions related to SURPASS should be submitted to [email protected].
Source: SAM.gov contract opportunities data (U.S. federal public data).
Incumbent
No incumbent history found for this requirement. The notice does not cite a current contract, and no earlier award from this buying office matches it.
Market context
Awards in the same category (Research and Development in Biotechnology (except Nanobiotechnology)). This is not this requirement's award history.
Recent similar awards: Department of Health and Human Services, NAICS 541714
| Vendor and award | Value | Ends |
|---|---|---|
| AMGEN USA INC75A50122C00065 · TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MA | $839.9M | Sep 29, 2032 |
| 4J THERAPEUTICS INC75A50124C00052 · THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO DEMONSTRATE THE VERSATILITY AND EFFICACY OF O | $63.1M | Mar 31, 2032 |
| BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL75A50124C00033 · THE DEVELOPMENT OF ANTIMICROBIALS FOR THE TREATMENT OF RESISTANT FUNGAL AND BACTERIAL INFE | $122.5M | Mar 31, 2032 |
| SRI INTERNATIONAL75N93026F00002 · TO AWARD TASK ORDER C03 | $722.0K | Feb 19, 2032 |
| ADVANCED TECHNOLOGY INTERNATIONAL75A50123F61002 · OT TASK ORDER 2 | $129.1M | Jan 31, 2032 |
Top vendors in this category: Department of Health and Human Services, NAICS 541714, since Oct 1, 2024
1,141 contract awards in this NAICS over the period.
- 1. ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE)$336.6M
- 2. AMGEN USA INC$215.9M
- 3. START2 GROUP, INC.$194.3M
- 4. SHIONOGI INC$156.1M
- 5. MAPP BIOPHARMACEUTICAL, INC.$133.1M
Source: USAspending.gov federal award data (U.S. federal public data). A contract is called the incumbent only when the notice or its documents cite it by number.
Source and verification
Original sourceCraxy AI summarizes this opportunity from the original listing and available solicitation documents. Confirm submission instructions and amendments with the issuing source before responding.
Personalized fit score
Sign up free to see how well this opportunity fits your company — based on your saved profile.
Sign up to see your fit score